(Q34394047)

1 August 2017

title

Risk factors for ifosfamide nephrotoxicity in children (English)

1 reference

1 August 2017

1 reference

R Skinner

1

1 reference

1 August 2017

A D Pearson

2

1 reference

1 August 2017

M W English

3

1 reference

1 August 2017

L Price

4

1 reference

1 August 2017

R A Wyllie

5

1 reference

1 August 2017

M G Coulthard

6

1 reference

1 August 2017

A W Craft

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

1 August 2017

1 reference

1 August 2017

volume

348

1 reference

1 August 2017

issue

9027

1 reference

1 August 2017

page(s)

578-580

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

1 August 2017

1 reference

7 January 2021

Ifosfamide in paediatric oncology: tried but not tested?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Renal function in children and adolescents following 72 g/m2 of ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Renal function abnormalities after ifosfamide treatment in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Ifosfamide, Fanconi's syndrome, and rickets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Nephrotoxicity after ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Nephrotoxicity associated with ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Ifosfamide, mesna, and nephrotoxicity in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Assessment of chemotherapy-associated nephrotoxicity in children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Fanconi syndrome after ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Hypophosphataemic rickets after ifosfamide treatment in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Reversible hypophosphatemic rickets following ifosfamide treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Acute ifosfamide-induced tubular toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

Ifosfamide-induced Fanconi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903480-0

7 January 2021

10.1016/S0140-6736(96)03480-0

Identifiers

DOI

1 reference

1 August 2017

1 reference